ArticleScientific reports2025
Tracing the evolutionary trajectory of Japanese encephalitis virus across hosts and countries.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Japanese Encephalitis Virus and Host Innate Immunity: Insights Into TLR Signaling, PRR Crosstalk, and Viral Immune Evasion.Cell biochemistry and function · 2026Review
- Advances and Challenges in Vaccination and Therapeutic Strategies Against Japanese Encephalitis Virus.Pathogens (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Japanese encephalitis Virus (JEV), the leading cause of epidemic encephalitis worldwide, is widespread across Asia and Australia cycling between vertebrate reservoir hosts and culicine mosquitoes. Change in dominant genotype, epidemics in new regions and re-emergence of dormant genotypes pose major public health concerns. To investigate the prevalent genotypes and their host range, JEV isolates were compiled from NCBI GenBank over a period of eight decades and full-length envelope gene sequences were analyzed. TMRCA analysis confirmed that JEV originated in the Indonesia-Malaysia region and subsequently diversified into multiple genotypes. Intriguing trends in the genotype distribution and the spread of the virus across various hosts and regions were observed. A notable change from GIII to GI is observed in many countries and distinct emergence and dispersion patterns across different regions and time periods were documented. The re-emergence of GIV in Indonesia after 37 years, coupled with its emergence in Australia highlight the need for critical control measures. Similarly, GV's resurgence in China after 57 years and its circulation in Korea emphasize the necessity of continuous genomic surveillance. Whole genome analysis further reinforced these findings, revealing a broader host range and deeper evolutionary insights, underscoring the urgency of proactive public health interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.